Compugen wins on PVRIG European patent opposition pursued by GSK, a third party Ruchika Sharma18 July 2023 2:39 PM ISTHolon: Compugen Ltd., a clinical-stage cancer immunotherapy company has announced that the broad claims of Compugen's Anti-PVRIG Antibodies...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
GSK RSV shot Arexvy approved in Britain for adults aged 60 years and older Ruchika Sharma10 July 2023 3:30 PM ISTBritain: Britain's health regulator approved GSK's vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and...
FDA grants fast-track designation to new gonorrhea vaccine Dr. Kamal Kant Kohli8 July 2023 9:45 AM ISTUSA: The US Food and Drug Administration (FDA) has granted Fast Track designation to the investigational gonorrhoea vaccine developed by drugmaker...
First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
GSK concludes acquisition of BELLUS Health Ruchika Sharma29 Jun 2023 1:30 PM ISTUpon completion of the Arrangement, GSK acquired all outstanding common shares of BELLUS for US$14.75 per common share in cash, representing a total...
USFDA grants fast track designation for GSK Neisseria gonorrhoeae investigational vaccine Ruchika Sharma27 Jun 2023 1:30 PM ISTGonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae.
Japan approves GSK shingles vaccine Shingrix for at risk adults aged 18 and over Ruchika Sharma27 Jun 2023 12:30 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix...
GSK reaches settlement in US Zantac litigation Ruchika Sharma23 Jun 2023 1:30 PM ISTUnited States: GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims that the British...
CDC panel advises Respiratory syncytial virus vaccination for elders Jacinthlyn Sylvia23 Jun 2023 9:30 AM ISTThe newly authorized respiratory syncytial virus (RSV) vaccinations should be given to persons aged 60 to 64 and 65 and older, according to the...
USFDA extends review period of GSK Momelotinib by three months Ruchika Sharma17 Jun 2023 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for...
GSK gets European Commission nod for RSV vaccine Arexvy for older adults Ruchika Sharma7 Jun 2023 1:30 PM ISTRespiratory syncytial virus vaccine, adjuvanted, contains recombinant glycoprotein F stabilised in the prefusion conformation.
